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 ABSTRACT                                                                                                                                            
Corpus callosum defect with dilated lateral ventricles 
and an occipital cyst in an Egyptian child with Dia-
mond-Blackfan anemia
Rabah M. Shawky1 and Nermine S. El-Sayed2
1Pediatric Department, 2Medical Genetics Center, Ain Shams University
Diamond-Blackfan anemia (DBA), an inherited bone marrow failure syndrome 
characterized by anemia that usually presents before the first birthday or in 
early childhood, is associated with birth defects and an increased risk of 
cancer. Although anemia is the most prominent feature of DBA, the disease 
is also characterized by growth retardation and congenital malformations, in 
particular craniofacial, upper limb, heart, and urinary system defects that are 
present in approximately 30%-50% of patients. Herein, we present a patient 
with Diamond-Blackfan anemia associated craniofacial anomalies, pyramidal 
manifestations and corpus callosum defect and dilated lateral ventricles opening 
with each other and opening with a posterior occipital cyst, an association that 
to date has not been reported.
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INTRODUCTION                                                                     
Diamond-Blackfan anaemia (DBA, 
OMIM #205900) was first reported by 
Josephs, 19361 and refined as a distinct 
clinical entity by Diamond and Black-
fan, 19382. It is now accepted that the 
disorder results from a cellular defect 
in which erythroid progenitors and pre-
cursors are highly sensitive to death by 
apoptosis, leading to erythropoietic fail-
ure. DBA is a member of a rare group of 
genetic disorders characterized by pro-
apoptotic hematopoiesis leading to bone 
marrow failure, congenital anomalies 
and predisposition to cancer, known as 
the inherited bone marrow failure syn-
dromes (IBMFS)3.
The first DBA gene, mutated in approxi-
mately 25% of patients, has been cloned 
and was identified as RPS19, which 
codes for a ribosomal protein located at 
chromosome 19q13.2. This protein plays 
a role in ribosome biogenesis. In patients 
with an RPS19 mutation, it has been 
proposed that the disease results from 
rps19 protein haploinsufficiency, i.e 
where the protein produced by a single 
copy of a normal gene is not sufficient 
to produce normal function. Recently de 
novo mutations have been identified in 
ribosomal proteins rps24, encoded by 
RPS24 at chromosome 10q22-q23 and 
in rps 17, encoded by RPS17 at chromo-
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some 15q25.2. Furthermore mutations 
in large ribosomal subunit-associated 
proteins rpl5, rpl11 and rpl35a have 
been described4-6.
The majority of cases are sporadic, with 
an equal sex ratio, but at least 10% have 
a positive family history for the disor-
der. Both autosomal dominant and auto-
somal recessive inheritance have been 
reported. In addition, studies of several 
families indicate dominant inheritance 
with reduced penetrance7.
A subset of patients has associated phe-
notypic abnormalities including thumb 
malformations, urogenital abnormali-
ties, atrial or ventricular septal defects, 
short stature, learning difficulties, stra-
bismus and cataract6.
CASE REPORT                                     
A 3.5 years old female patient was born 
at term after an uneventful pregnancy to 
unrelated parents. The parents and the 
older brother were all healthy; however, 
the paternal aunt and the paternal aunt 
of the mother had leukemia and died 
at the age of 25y and 32y respectively. 
At the age of 2 months, the proband 
developed pallor and fever (39°C) and 
she received her first blood transfusion, 
later she became transfusion dependent 
every 15 days. 
On examination, she had anemia, with 
no palpable liver and spleen. Her length 
was 84cm, weight was 10kg and head 
circumference was 47cm (all below the 
third percentile). Craniofacial examina-
tion revealed prominent forehead, up-
ward slant of lateral palpebral fissures, 
low set ear, prominent upper jaw, high 
arched palate and thick everted lower 
lip. Skeletal examination revealed lim-
ited extension of elbows and knees and 
dorsiflexion of big toes. Neurologic 
examination showed mental impair-
ment, hypertonia and exaggerated deep 
reflexes and +ve babiniski sign. Other 
systems were normal.
Laboratory investigations revealed a 
hemoglobin concentration of 4g/dl. re-
ticulocytopenia, leukocyte and throm-
bocyte counts were normal. A bone 
marrow aspirate showed a selective 
decrease in erythroid precursors and 
reduced erythropoiesis confirming the 
diagnosis of congenital pure red cell 
aplasia. 
CT brain detected associated malforma-
tions in the form of corpus callosum de-
fect with dilated lateral ventricles open-
ing with each other and opening with a 
posterior occipital cyst as well (Fig. 1). 
Electroencephalography, echocardiog-
raphy and abdominal U/S and chromo-
somal analysis (G-banding) were nor-
mal.
Fig. 1: CT brain shows a corpus callosum 
defect with dilated lateral ventricles open-
ing with each other and opening with a pos-
terior occipital cyst as well.
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DISCUSSION                                         
Diamond Blackfan anemia was first 
described as a disorder of impaired red 
cell production in children. The presen-
tation in adults, the risk of other cyto-
penias, the predisposition to cancer and 
the high incidence of birth defects are 
now being quantified8.
The diagnostic criteria for DBA, pre-
sented in 19769, have remained the ac-
cepted standard. These include anemia, 
presenting prior to the first birthday, 
with near normal, variable, neutrophil 
and /or platelet counts, reticulocytope-
nia, macrocytosis and normal marrow 
cellularity with a paucity of red cell 
precursors. Our patient manifestations 
were compatible with the diagnosis of 
DBA. 
Certainly these diagnostic criteria de-
fine “classic” DBA. It is apparent from 
the study of multiplex families that af-
fected individuals may present in “non-
classical” ways. For example, individu-
als may present at an age greater than 
one year, only with congenital anoma-
lies, without anemia or with a mild he-
matological phenotype (macrocytosis 
only). These cases of “non-classical” 
DBA need to be more carefully iden-
tified, particularly when reproductive 
choices and transplant donor decisions 
are being made5.
Until recently, information with regard 
to the cancer risk in patients with DBA 
has been limited primarily to case re-
ports: 29 cases were reported among 
more than 700 patients in the litera-
ture10, 11. The reported proportion of 4% 
is higher than the expected <1% for a 
cohort less than 30 years of age. The 
median age for cancer in these reports 
was 15 years, much younger than the 
median of 68 years in the general popu-
lation. While the published data are in-
sufficient to define the risk of cancer in 
DBA, the types of malignancy reported 
are informative. The literature includes 
11 cases of acute leukemia (10 acute 
myeloid leukemia [AML] and one acute 
lymphoblastic leukemia), three cases of 
myelodysplastic syndrome that did not 
develop AML, six cases of sarcoma 
(five osteogenic, one soft tissue), three 
Hodgkin lymphoma, two breast cancer, 
two hepatocellular carcinoma and one 
each of melanoma, fibrohistiocytoma, 
non-Hodgkin lymphoma, gastric cancer 
and colon cancer5, 10-12.
Congenital anomalies observed in DBA 
may involve the head, upper limbs, 
heart and genitourinary system (Table 
1). More than one anomaly is found 
in up to 25% of individuals. There is 
a wide range of severity of congeni-
tal anomalies in DBA, with variability 
even within the same kindred. 
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Craniofacial anomalies are the most 
common, representing 50% of con-
genital anomalies reported to the North 
American DBA Registry, with hyper-
telorism and broad flat nasal bridge 
contributing to the classic DBA facies 
described by Cathie13. In our patient 
the most prominent craniofacial abnor-
malities included prominent forehead, 
upward slant of lateral palpebral fis-
sure, high arched palate, low set ear, 
thick everted lower lip and prominent 
upper jaw. Thumb anomalies have been 
described in 9-19% of patients. The 
severity of abnormalities ranges from 
hypoplasia of the thenar eminence to 
absence of the radius or forearm, dupli-
cated bifid or the classic triphalangeal 
thumb14. In our case limited extension 
of elbows and knees and dorsiflexion of 
big toes were the only upper limb ab-
normalities detected. Renal and cardiac 
anomalies have each been described in 
up to 7% of patients in the UK, France 
and Italy. However, in the North Ameri-
can Diamond Blackfan Anemia Reg-
istry (DBAR), where the majority of 
patients undergo formal genitourinary 
and cardiac imaging, the prevalence is 
higher at 19% and 15%, respectively5. 
In our case no cardiac or abdominal ab-
normalities were detected.
Growth retardation (height below 3rd 
centile for age) is described in approxi-
mately 30% of children as well in our 
case. It must be noted that stature is dif-
ficult to evaluate in the context of se-
vere anemia, iron overload and chronic 
corticosteroids use. Growth retardation 
is commonly associated with physical 
abnormalities and can thus be consid-
ered part of the spectrum of congenital 
anomalies15. In a study of 22 Egyptian 
patients with Diamond Blackfan ane-
mia, there were associated congeni-
tal anomalies in 5 patients (22.7%) as 
polycystic kidney and cavernoma of the 
portal vein in 1 patient, hypospadius in 
another patient, short stature in 1 patient 
and microcephaly in 2 patients16. How-
ever, the link between these malforma-
tions and defective erythropoiesis is un-
clear and a defect in molecule acting on 
Table 1: Range of congenital anomalies observed in Diamond Blackfan anemia (DBA)*.
Craniofacial
Hypertelorism, broad, flat nasal bridge, cleft palate, high arched palate, 
microcephaly, micrognathia, microtia, low set ears, low hair line, epicanthus, 
ptosis.
Ophthalmological Congenital glaucoma, strabismus
Neck Short neck, webbed neck, Sprengel deformity, Klippel-Feil deformity.
Thumbs
Triphalyngeal, duplex or bifid, hypoplastic, flat thenar eminence, absent radial 
artery.
Urogenital Absent kidney, horseshoe kidney, hypospadias
Cardiac
Ventricular septal defect, atrial septal defect, coarctation of the aorta, complex 
cardiac anomalies
Other musculoskeletal Growth retardation, syndactyly
Neuromotor Learning difficulties
* The list includes the anomalies that are most characteristic of DBA, but is not exhaustive5.
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both early embryonic development and 
hematopoiesis has been proposed17.
In our patient, associated malforma-
tions were craniofacial anomalies, 
pyramidal manifestations and corpus 
callosum defect with dilated lateral 
ventricles opening with each other and 
opening with posterior occipital cyst as 
well. There were no previous reports of 
such association. One report18 described 
a patient who had concomitant pure red 
cell aplasia, thymoma, myasthenia gra-
vis and a normal pressure hydrocepha-
lus. However, he was 63 years old and 
had pure red cell aplasia most probably 
of immunological origin. Indeed, this 
case illustrates the need for heightened 
awareness about the existence of CNS 
malformations in patients with DBA 
and lengthens the list of associated 
congenital anomalies. Furthermore as 
the analysis of the family pedigree re-
vealed two leukemic family members 
died at the age of 25y and 32y respec-
tively and as the risk of malignancy and 
other complications of DBA are better 
defined, the proband and all immediate 
family members should be evaluated 
thorough relevant history (anemia, can-
cer, birth defects), physical examina-
tion with blood count monitoring, brain 
imaging, renal imaging and echocardio-
gram. Other specialist referrals should 
also be made as indicated.
REFERENCES                                                                      
1. Josephs HW. Anemia of infan-
cy and early childhood. Medicine 
1936;15:307.
2. Diamond LK and Blackfan KD. Hy-
poplastic anemia. Am.J.Dis.Child. 
1938;56:464-7.
3. Young NS, Alter BP. Inherited bone 
marrow failure syndromes: Introduc-
tion. In: Young NS, Alter BP, editors. 
Aplastic anemia acquired and inherited 
Philadelphia: WB Saunders Company; 
1994. p. 271-4.
4. Gregory LA, Aguissa-Touré AH, Pin-
aud N, Legrand P, Gleizes PE and Fri-
bourg S. Molecular basis of Diamond-
Blackfan anemia: Structure and func-
tion analysis of RPS19. Nucleic Acids 
Res. 2007;35(17):5913-21.
5. Vlachos A, Ball S, Dahl N, Alter BP, 
Sheth S, Ramenghi U, et al. Diagnosing 
and treating Diamond Blackfan anae-
mia: Results of an international clinical 
consensus conference. Br.J.Haematol. 
2008;142(6):859-76.
6. Crétien A, Proust A, Delaunay J, Rincé 
P, Leblanc T, Ducrocq R, et al. Ge-
netic variants in the noncoding region 
of RPS19 gene in Diamond-Blackfan 
anemia: Potential implications for phe-
notypic heterogeneity. Am.J.Hematol. 
2010;85(2):111-6.
7. Madanat F, Arnaout M, Hasan A, 
Tarawneh M, Shomaf M and Kha-
layleh F. Red cell aplasia resembling 
Diamond-Blackfan anemia in seven 
children in a family. Am.J.Pediatr.He-
matol.Oncol. 1994;16(3):260-5.
8. Orfali KA, Ohene-Abuakwa Y and 
Ball SE. Diamond Blackfan anaemia in 
the UK: Clinical and genetic heteroge-
neity. Br.J.Haematol. 2004;125(2):243-
52.
9. Diamond LK, Wang WC and  Alter BP. 
Congenital hypoplastic anemia. Adv.
Pediatr. 1976;22(349):378.
10. Alter BP. Inherited bone marrow fail-
ure syndromes. In: Nathan DG, Orkin 
90
Corpus callosum defect in DBA
SH, Look AT, Ginsburg D, editors. Na-
than and Oski’s hematology of infancy 
and childhood. 6th ed. Philadelphia, PA: 
WB Saunders; 2003. p. 280-365.
11. Yaris N, Erduran E and  Cobanoglu 
U. Hodgkin lymphoma in a child with 
Diamond Blackfan anemia. J.Pediatr.
Hematol.Oncol. 2006;28(4):234-6.
12. Ries LAG, Eisner MP, Kosary CL, 
Hankey BF, Miller BA, Clegg L, et al. 
SEER Cancer Statistics Review, 1973-
1998. Bethesda, MD: National Cancer 
Institute; 2001.
13. Cathie IA. Erythrogenesis imperfecta. 
Arch.dis.child. 1950;25(124):313-24.
14. Lipton JM and Ellis SR. Diamond-
Blackfan anemia: Diagnosis, treatment 
and  molecular pathogenesis. Hematol.
Oncol.Clin.North Am. 2009;23(2):261-
82.
15. Chen S, Warszawski J, Bader-Meunier 
B, Tchernia G, Da Costa L, Marie I, 
et al. Diamond-blackfan anemia and 
growth status: The French registry. 
J.Pediatr. 2005;147(5):669-73.
16. El-Beshlawy A, Ibrahim IY, Rizk S and 
Eid K. Study of 22 Egyptian patients 
with Diamond-Blackfan anemia, corti-
costeroids and cyclosporin therapy re-
sults. Pediatrics 2002;110(4):e44.
17. Manglani M, Lokeshwar MR and 
Sharma R. Diamond-Blackfan ane-
mia: Report of 6 cases. Indian Pediatr. 
2003;40(4):355-8.
18. Akimoto Y, Ishiyama T, Ueno H, Hino 
K, Tomoyasu S, Tsuruoka N, et al. 
Pure red cell aplasia with thymoma, 
myasthenia gravis and normal pres-
sure hydrocephalus. [Rinsho ketsueki] 
Jap.j.clin.hematol. 1994;35(8):780-5..
